Muh-Hwa Yang

24PUBLICATIONS
108CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 02, 2026
Histopathology-inferred spatial transcriptomics characterizes the tumor microenvironment in 1,500 head and neck tumors and predicts clinical outcomes.

|May 31, 2026
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|Jan 08, 2026
Multi-agent chemotherapy for refractory head and neck cancer.

I-Wei Ho, Tien-Hua Chen, Peter Mu-Hsin Chang

|Jun 13, 2025
GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study.

Lin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang

|Apr 29, 2025
Primary Laryngeal Squamous Cell Carcinoma with DEK::AFF2 Fusion: The First Case Report.

Alan Yan-Lun Huang, Ying-Ju Kuo, Muh-Hwa Yang

|Feb 11, 2025
Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8+ T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1.

Wen-Hao Yang, Bao-Yue Huang, Hsing-Yu Rao

Pageof 4

Frequent Collaborators

2 joint publications

Tsai-Tsen Liao

2 joint publications

Rui-Hua Xu

2 joint publications

Ying-Ju Kuo

2 joint publications

Patricia Keegan